Katharina Kreymborg
Private Equity Investor bij Versant Venture Management LLC
Oorsprong van het eerstegraads netwerk van Katharina Kreymborg
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
University of Zurich
40
| College/University | Other Consumer Services | 40 |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver.
34
| Holding Company | Investment Managers | 34 |
Eberhard Karls Universität Tübingen
8
| College/University | Other Consumer Services | 8 |
| Public Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Katharina Kreymborg via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Private Equity Investor | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| SCHWEIZERISCHE NATIONALBANK | Major Banks | Director/Board Member Chief Executive Officer | |
| MOBIMO HOLDING AG | Real Estate Development | Director of Finance/CFO Corporate Officer/Principal | |
Capvis AG
 Capvis AG Investment ManagersFinance Capvis AG (Capvis), formerly known as Capvis Equity Partners AG, is an independent Swiss private equity firm headquartered in Baar, Switzerland, with additional offices in Frankfurt am Main (Germany), Shanghai (China), Jersey (Channel Islands), Luxembourg and Amsterdam (the Netherlands). The firm was established in 1990. | Investment Managers | Private Equity Investor Human Resources Officer Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| Golden Gate University | College/University | Graduate Degree Graduate Degree | |
| University of Toronto | College/University | Doctorate Degree Doctorate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of St. Gallen | College/University | Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Doctorate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Bern | College/University | Graduate Degree Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Private Equity Investor | |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Chairman | |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
ERNI Liegenschaften AG
 ERNI Liegenschaften AG Electronic ComponentsElectronic Technology ERNI Liegenschaften AG engages in the acquisition, construction, holding, management, and sale of real estate properties in Switzerland and abroad. It also provides financing, administrative, as well as fiduciary services. The company was founded on June 1, 1984 and is headquartered in Bruettisellen, Switzerland. | Electronic Components | Director/Board Member Director/Board Member | |
| National Centre of Competence in Research | Corporate Officer/Principal Corporate Officer/Principal | ||
QualySense AG
 QualySense AG Trucks/Construction/Farm MachineryProducer Manufacturing QualySense AG develops solutions for grains, seeds and beans sorting. It offers QSorer Explorer is the novel single kernel method to inspect reliability and accurately for gluten contaminations during intake and processing. The firm provides seed breeding, quality inspection, size separation, color sorting, seed processing and purity inspection services. The company was founded by Francesco Dell'Endice, Paolo D'Alcini, Olga Mykhailova-Peters, Stefan Blarer and Alberto E. Romaneschi in 2009 and is headquartered in Glattbrugg, Switzerland. | Trucks/Construction/Farm Machinery | Founder Chief Tech/Sci/R&D Officer | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Inception Sciences, Inc.
 Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Inception Sciences, Inc. provides small molecule pharmaceutical incubator services. Its focus is on creating therapies with transformative potential to address diseases and disorders. The company creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded in 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| CRISPR THERAPEUTICS AG | Biotechnology | Chairman Director/Board Member Chief Operating Officer | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member Founder Corporate Officer/Principal | |
MMI Munich Medical International GmbH
 MMI Munich Medical International GmbH Other Consumer ServicesConsumer Services MMI Munich Medical International GmbH offers healthcare business services. It provides hospital planning services, investment advices, strategic planning services, feasibility studies and analyses, advanced training for medical faculties and health care services for universities and health care businesses. The company was founded in 2005 and is headquartered in Munich, Germany. | Other Consumer Services | Corporate Officer/Principal Corporate Officer/Principal | |
Blueline Bioscience
 Blueline Bioscience Investment ManagersFinance Blueline Bioscience acts as an alternative investment manager. The company is headquartered in Toronto, Canada. | Investment Managers | Director/Board Member Director/Board Member | |
Inception IBD, Inc.
 Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
Kyras Therapeutics, Inc.
 Kyras Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kyras Therapeutics, Inc. operates as a biopharmaceutical company that develops drugs for incurable cancers and developmental disorders caused by RAS gene mutations. The company was founded by Brent R. Stockwell in 2015 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Versant Venture Capital VI (Canada) LP
 Versant Venture Capital VI (Canada) LP Investment ManagersFinance Versant Venture Capital VI (Canada) LP operates as a pooled investment fund. The company is headquartered in San Francisco, CA. | Investment Managers | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Jecure Therapeutics, Inc.
 Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
CODA Biotherapeutics, Inc.
 CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA. | Medical Specialties | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Mobimo Zürich Nord AG | Director/Board Member Director/Board Member | ||
Vensana Capital Management LLC
 Vensana Capital Management LLC Investment ManagersFinance Vensana Capital Management LLC (Vensana Capital) is a venture capital and growth equity investment firm founded in 2019 by Peter Klein Justin & Kirk G. Nielsen. The firm is headquartered in Saint Paul, Minnesota. | Investment Managers | Consultant / Advisor Founder | |
Monte Rosa Therapeutics AG
 Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
858 Therapeutics, Inc.
 858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Ventus Therapeutics U.S., Inc.
 Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Medical Distributors | Director/Board Member Chief Executive Officer | |
Ventus Therapeutics, Inc.
 Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Erni Real Estate AG | Director/Board Member Director/Board Member | ||
| Projektkontor AG | Director/Board Member Director/Board Member | ||
Santa Ana Bio, Inc.
 Santa Ana Bio, Inc. BiotechnologyHealth Technology Santa Ana Bio, Inc. is a biotechnology company that specializes in precision immunology for autoimmune diseases. The company is based in Alameda, CA. The CEO of the company is Peter Emtage. | Biotechnology | Chief Executive Officer Director/Board Member | |
| CONTINEUM THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 27 |
| Zwitserland | 19 |
| Canada | 4 |
| Duitsland | 3 |
Sectoraal
| Health Technology | 20 |
| Consumer Services | 11 |
| Finance | 8 |
| Commercial Services | 6 |
| Electronic Technology | 2 |
Operationeel
| Director/Board Member | 228 |
| Corporate Officer/Principal | 130 |
| Private Equity Investor | 57 |
| Undergraduate Degree | 51 |
| Graduate Degree | 46 |
Sterkste connecties
| Insiders | |
|---|---|
| Bradley Bolzon | 41 |
| Thomas Woiwode | 39 |
| Kirk Nielsen | 25 |
| Jeremy S. Caldwell | 22 |
| Carlo Rizzuto | 22 |
| Paul Grayson | 21 |
| Stefan Hilber | 18 |
| Rajna Gibson Brandon | 15 |
| Florian Marxer | 14 |
| Richard D. van Doren | 14 |
| Clare Ozawa | 14 |
| Gianni Gromo | 14 |
| Kaspar Andreas Hemmeler | 14 |
| Axel Bouchon | 11 |
| Rolf Engel | 11 |
- Beurs
- Insiders
- Katharina Kreymborg
- Bedrijfsconnecties
